Literature DB >> 16424532

Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration.

C G Pieroni1, A J Witkin, T H Ko, J G Fujimoto, A Chan, J S Schuman, H Ishikawa, E Reichel, J S Duker.   

Abstract

AIM: To describe the appearance of the non-exudative forms of age related macular degeneration (AMD) as imaged by ultrahigh resolution optical coherence tomography (UHR-OCT).
METHODS: A UHR-OCT ophthalmic imaging system, which utilises a femtosecond laser light source capable of approximately 3 mum axial resolution, was employed to obtain retinal cross sectional images of patients with non-exudative AMD. Observational studies of the resulting retinal images were performed.
RESULTS: 52 eyes of 42 patients with the clinical diagnosis of non-exudative AMD were imaged using the UHR-OCT system. 47 of the 52 (90%) eyes had the clinical diagnosis of drusen and/or retinal pigment epithelial (RPE) changes. In these patients, three patterns of drusen were apparent on UHR-OCT: (1) distinct RPE excrescences, (2) a saw toothed pattern of the RPE, and (3) nodular drusen. On UHR-OCT, three eyes (6%) with a clinical diagnosis of non-exudative AMD had evidence of fluid under the retina or RPE. Two of these three patients had findings suspicious for subclinical choroidal neovascularisation on UHR-OCT.
CONCLUSION: With the increased resolution of UHR-OCT compared to standard OCT, the involvement of the outer retinal layers are more clearly defined. UHR-OCT may allow for the detection of early exudative changes not visible clinically or by angiography.

Entities:  

Mesh:

Year:  2006        PMID: 16424532      PMCID: PMC1860181          DOI: 10.1136/bjo.2005.076612

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  26 in total

1.  Ultrahigh resolution optical coherence tomography of the monkey fovea. Identification of retinal sublayers by correlation with semithin histology sections.

Authors:  Elisabeth M Anger; Angelika Unterhuber; Boris Hermann; Harald Sattmann; Christian Schubert; James E Morgan; Alan Cowey; Peter K Ahnelt; Wolfgang Drexler
Journal:  Exp Eye Res       Date:  2004-06       Impact factor: 3.467

2.  Optical coherence tomography.

Authors:  D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

3.  Evolution of soft drusen in age-related macular degeneration.

Authors:  J P Sarks; S H Sarks; M C Killingsworth
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

4.  Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study.

Authors:  C C Klaver; R C Wolfs; J R Vingerling; A Hofman; P T de Jong
Journal:  Arch Ophthalmol       Date:  1998-05

5.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1999-10

6.  Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group.

Authors:  S B Bressler; M G Maguire; N M Bressler; S L Fine
Journal:  Arch Ophthalmol       Date:  1990-10

7.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S C Jensen; S M Meuer
Journal:  Ophthalmology       Date:  1997-01       Impact factor: 12.079

8.  Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to management--TAP report No. 6.

Authors:  Susan B Bressler; Dante J Pieramici; John M Koester; Neil M Bressler
Journal:  Arch Ophthalmol       Date:  2004-03

9.  Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.

Authors:  Keven J Blinder; Shannon Bradley; Neil M Bressler; Susan B Bressler; Guy Donati; Yong Hao; Colin Ma; Ugo Menchini; Joan Miller; Michael J Potter; Constantin Pournaras; Al Reaves; Philip J Rosenfeld; H Andrew Strong; Michael Stur; Xiang Yao Su; Gianni Virgili
Journal:  Am J Ophthalmol       Date:  2003-09       Impact factor: 5.258

10.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.

Authors:  Ronald Klein; Barbara E K Klein; Sandra C Tomany; Stacy M Meuer; Guan-Hua Huang
Journal:  Ophthalmology       Date:  2002-10       Impact factor: 12.079

View more
  29 in total

1.  Association between retinal thickness measured by spectral-domain optical coherence tomography (OCT) and rod-mediated dark adaptation in non-exudative age-related maculopathy.

Authors:  Mark E Clark; Gerald McGwin; David Neely; Richard Feist; John O Mason; Martin Thomley; Milton F White; Bunyamin Ozaydin; Christopher A Girkin; Cynthia Owsley
Journal:  Br J Ophthalmol       Date:  2011-02-02       Impact factor: 4.638

2.  Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography.

Authors:  Joseph Ho; Andre J Witkin; Jonathan Liu; Yueli Chen; James G Fujimoto; Joel S Schuman; Jay S Duker
Journal:  Ophthalmology       Date:  2010-11-20       Impact factor: 12.079

3.  Histologic and Optical Coherence Tomographic Correlates in Drusenoid Pigment Epithelium Detachment in Age-Related Macular Degeneration.

Authors:  Chandrakumar Balaratnasingam; Jeffrey D Messinger; Kenneth R Sloan; Lawrence A Yannuzzi; K Bailey Freund; Christine A Curcio
Journal:  Ophthalmology       Date:  2017-01-30       Impact factor: 12.079

4.  Optical Coherence Tomography for Ophthalmology Imaging.

Authors:  Jia Qin; Lin An
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs.

Authors:  Nieraj Jain; Sina Farsiu; Aziz A Khanifar; Srilaxmi Bearelly; R Theodore Smith; Joseph A Izatt; Cynthia A Toth
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-14       Impact factor: 4.799

6.  Assessing the photoreceptor mosaic over drusen using adaptive optics and SD-OCT.

Authors:  Pooja Godara; Cory Siebe; Jungtae Rha; Michel Michaelides; Joseph Carroll
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010 Nov-Dec

7.  Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration.

Authors:  Giovanni Gregori; Fenghua Wang; Philip J Rosenfeld; Zohar Yehoshua; Ninel Z Gregori; Brandon J Lujan; Carmen A Puliafito; William J Feuer
Journal:  Ophthalmology       Date:  2011-03-09       Impact factor: 12.079

8.  Projection OCT fundus imaging for visualising outer retinal pathology in non-exudative age-related macular degeneration.

Authors:  I Gorczynska; V J Srinivasan; L N Vuong; R W S Chen; J J Liu; E Reichel; M Wojtkowski; J S Schuman; J S Duker; J G Fujimoto
Journal:  Br J Ophthalmol       Date:  2008-07-28       Impact factor: 4.638

9.  Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.

Authors:  Jessica N Leuschen; Stefanie G Schuman; Katrina P Winter; Michelle N McCall; Wai T Wong; Emily Y Chew; Thomas Hwang; Sunil Srivastava; Neeru Sarin; Traci Clemons; Molly Harrington; Cynthia A Toth
Journal:  Ophthalmology       Date:  2012-09-08       Impact factor: 12.079

10.  Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci.

Authors:  Joseph G Christenbury; Francisco A Folgar; Rachelle V O'Connell; Stephanie J Chiu; Sina Farsiu; Cynthia A Toth
Journal:  Ophthalmology       Date:  2013-01-23       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.